fezakinumab

Ligand id: 9281

Name: fezakinumab

References
1. Fouser LA, Hegen M, Luxenberg DP, O'Toole M. (2010)
Methods of using antibodies against human IL-22.
Patent number: US7811567. Assignee: Wyeth Llc. Priority date: 21/02/2006. Publication date: 12/10/2010.